Tech24 » Gadgets http://www.tech24.org Latest news on Technology Fri, 14 Sep 2012 13:44:00 +0000 en-US hourly 1 http://wordpress.org/?v=3.4.2 Graystone Co. Inc. (GYST) Stock closes Up in Wednesday’s Session http://www.tech24.org/142571graystone-co-inc-gyst-stock-closes-up-in-wednesdays-session.html http://www.tech24.org/142571graystone-co-inc-gyst-stock-closes-up-in-wednesdays-session.html#comments Thu, 13 Sep 2012 13:03:14 +0000 Wise Ahadzi http://www.tech24.org/?p=14257 Graystone Co. Inc.  (OTC: GYST) stock closed Wednesday at $0.0126, up 80 percent from its previous close. Its trading volume recorded at 75.85 million shares, in contrast to the average daily trading volume of 13.35 million shares. The company’s market capitalization stands at $2.32 million. GYST reported its latest Earnings per Share at -$5.04. The company has 184.24 million shares outstanding in the market. GYST stock is currently trading above its short term 20-days moving average price and its long term 50-days moving average price.

GYST recently launched its new Website for the purpose of selling gold and silver. The company also collaborates with E-bay for this purpose. GYST announced that it would hold its shareholders meeting in California on October 1, 2012. The company is not expected to put any matter for voting. However, it will update the stockholders about the future course of action for the company.

GYST reported record sale for the month of August. The company said that it sold more gold and silver in a single month than it did in the rest of the year combined. GYST recorded 341 percent surge in its retail sales of metals like gold and silver. Paul Howarth, CEO of the company said, “In fact, the retail division has grown faster than we expected – we sold more gold and silver in August then the rest of the year combined and we look forward to continued growth the rest of the year.”

GYST is engaged in the business of mining precious metals including gold and silver. The company also carries out various other business activities such providing strategic and financial consultancy services. The GYST is mainly operational in Peru.  It also has real estate related business in the United States. The company carries out these businesses through its subsidiaries. The GYST was formed in 2010. It is based out of New York.

]]> http://www.tech24.org/142571graystone-co-inc-gyst-stock-closes-up-in-wednesdays-session.html/feed 0 Pristine Solutions Inc. (PRTN) Closes Up in Tuesday’s Trading Session http://www.tech24.org/142151pristine-solutions-inc-prtn-closes-up-in-tuesdays-trading-session.html http://www.tech24.org/142151pristine-solutions-inc-prtn-closes-up-in-tuesdays-trading-session.html#comments Wed, 12 Sep 2012 12:44:58 +0000 Terrel Sugar http://www.tech24.org/?p=14215 Pristine Solutions Inc. (OTC: PRTN) stock closed Tuesday at $0.39, up 11.14 percent from its previous close of $0.35. The stock opened the session at $0.37 and touched its highest price point at $0.40. PRTN’s lowest price point for the session stood at $0.35. Its latest trading volume has been recorded at 8.48 million shares, in contrast to the average daily trading volume of 22.34 million shares. The company’s market capitalization stands at $146.30 million. PRTN stock is currently trading above its short-term 20-days moving average price and its long-term 50-days moving average price of $0.38.

PRTN recently completed the acquisition of Eaton Scientific Systems Ltd. With this acquisition, the company has set foot in women’s health and drug market. Eaton has developed a novel indication for Homatropine. The drug is meant to be used for treating hot flashes in women. Michael Borkowski, President and CEO of Eaton said, “We look forward to building market awareness and acceptance of Tropine 3 throughout the women’s health care sector in hopes of improving the lives of the over 50 million women in America.”

Eaton Scientific Systems carries out its operations as the fully owned subsidiary of PRTN.

PRTN did not earn any revenue for its quarter ended on April 30, 2012, and suffered operating loss of $10,000. The company had $4,000 in cash and cash equivalents as of the end of the quarter and its total current assets stands at $11,000. PRTN reported its Accounts Payable at $16,000 and its current debt stood at $38,000. The company reproved its total shareholder equity at -$38,000 as of the end of the quarter.

PRTN is in the business of developing sales network for tankless water heaters. The company also holds license to female health products through its wholly owned subsidiary Eaton Scientific Systems. The company markets its products to corporate clients, retail clients, builders, governments and contractors. PRTN is a development stage company formed in 2009. The company is based out of Trelawny in Jamaica.

]]> http://www.tech24.org/142151pristine-solutions-inc-prtn-closes-up-in-tuesdays-trading-session.html/feed 0 Geron Corp. (GERN) Stock Continues Slide in Monday’s Session http://www.tech24.org/141921geron-corp-gern-stock-continues-slide-in-mondays-session.html http://www.tech24.org/141921geron-corp-gern-stock-continues-slide-in-mondays-session.html#comments Tue, 11 Sep 2012 16:10:49 +0000 James Mac http://www.tech24.org/?p=14192 Geron Corp. (NASDAQ: GERN) stock is currently trading at $1.25, down 1.95 percent from its previous close of $1.28. The stock opened the session at $1.26 and touched its highest price point at $1.27. GERN stock’s lowest price point for the session stood at $1.21. Its latest trading volume has been recorded at 2.377 million shares, in contrast to the average daily trading volume of 1.274 million shares. The company’s market capitalization stands at $165.39 million. GERN reported its latest Earnings per Share at -$0.70.

The company has 131.26 million shares outstanding in the market and institutional investors own 28 percent of its share capital. GERN stock is currently trading below its short term 20 days moving average price of $1.26. It is also trading at level to its long term 50 days moving average price of $1.25. The company stock’s beta is 1.07.

GERN stock has been downgraded by equity research firm Stifel Nicolaus. The stock is now rated as Hold, down from its previous rating of Buy. GERN stock tumbled in the previous trading session following the negative news pertaining to its drug candidate Imetelstat. The drug is being tested for treating breast cancer and other cancers. The company terminated mid stage trial for the drug’s use as breast cancer therapy and claimed that the women treated with this drug did worse than the women on standard chemotherapy only. The company did not disclose if it would be carrying out any other mid stage trial for the drug.

GERN will still carry out the drug trials for treating essential thrombocythemia and multiple myeloma. The company will also continue testing Imetelstat for treating two types of blood cancer. It is expected to provide results of these tests in the fourth quarter of 2012. However, it would not be moving forward with the drug testing for advanced non-small cell lung cancer.

GERN is biopharmaceutical company and is involved in the business of developing various therapies for treating cancer. The company’s main drug candidates were GRN1005 and Imetelstat. GRN1005 is a lipoprotein receptor-related protein-1 directed peptide-drug conjugate and Imetelstat is a telomerase inhibitor. The company is based out of Menlo Park in California and was formed in 1990.

]]> http://www.tech24.org/141921geron-corp-gern-stock-continues-slide-in-mondays-session.html/feed 0 Southridge Enterprises Inc. (SRGE) rises in Monday’s Trading Session http://www.tech24.org/141711southridge-enterprises-inc-srge-rises-in-monday%e2%80%99s-trading-session.html http://www.tech24.org/141711southridge-enterprises-inc-srge-rises-in-monday%e2%80%99s-trading-session.html#comments Tue, 11 Sep 2012 12:58:01 +0000 Tammy Dugas http://www.tech24.org/?p=14171 Southridge Enterprises Inc. (OTC: SRGE) traded in the range of $0.00 and $0.01 during Monday’s trading session. The stock closed at $0.0074, up 89.74 percent from its previous close. SRGE recorded a volume of 192.45 million shares. Its average daily trading volume stands at 21.01 million shares. The company stock has traded in the range of $0.00 and $0.01 during its past 52 weeks. SRGE has market capitalization of $6.24 million. The company has 843.08 million shares outstanding in the market. The company stock is trading below both the short-term 20-days moving price and long-term 50-days moving average price of $0.01. SRGE stock has beta of -14.22.

SRGE reported that it has started work on expanding its Cinco Minas Mill. The mill is located in Mexico at Cinco Minas. The new expansion will increase the production capacity to 500 tons per day. The current production rate stands at 60 tons per day. The expansion is likely to be completed by the end of 2013. Michael Davies, president and CEO of the company said, “The goal moving forward is to bring the company’s shareholders added value by increasing revenues, using economies of scale to reduce costs and expand our mineral resources through exploration.”

SRGE also announced its fourth-quarter results. The company earned $3.14 million in revenue for the quarter. This quarter produced record mineral production and revenue for the company. It processed more than 9,000 tons of mineral during the quarter. The company is currently working towards reclaiming its reporting status for Over the Counter Bulletin Board.

SRGE is involved in the business of acquiring, exploring and developing gold and silver mines. The company is mainly operational in Mexico and operates through its subsidiaries Southridge Minerals Inc. the company also has 100 percent stake in the Cinco Minas property. This property is spread over an area of 10,750 hectares and is located in the city of Guadalajara. SRGE also holds an option to acquire 40 percent interest in Esperanza property in Jalisco. The company is based out of Dallas, Texas and was established in 2004.

]]> http://www.tech24.org/141711southridge-enterprises-inc-srge-rises-in-monday%e2%80%99s-trading-session.html/feed 0 Stevia First Corp. (STVF) Stock Closes Down in Friday’s Trading Session http://www.tech24.org/141271stevia-first-corp-stvf-stock-closes-down-in-friday%e2%80%99s-trading-session.html http://www.tech24.org/141271stevia-first-corp-stvf-stock-closes-down-in-friday%e2%80%99s-trading-session.html#comments Mon, 10 Sep 2012 12:55:57 +0000 Arnulfo Saucedo http://www.tech24.org/?p=14127 Stevia First Corp. (OTC: STVF) traded in the range of $0.62 and $0.84 during its latest trading session. The stock opened at $0.70 and closed at $0.65, down 3.70 percent from its previous close. STVF has average daily trading volume stands at 256K shares. The company stock has traded in the range of $0.23 and $3.28 during its past 52 weeks. STVF has market capitalization of $34.05 million and it reported its latest Earnings per Share at -$0.04. The company stock is trading above both the short term 20 days moving price of $0.53. It is also trading above its long term 50 days moving average price of $0.62.

STVF is scheduled to make a presentation at Rodman & Renshaw Annual Global Investment Conference to be held in New York State. The conference will last till September 11, 2012. The company CEO Robert Brooke will provide latest news about the company’s future plans and actions.

The company has also licensed intellectual property rights from Vineland Research and Innovation Centre. Robert Brooke, CEO of Stevia First Corp., commented on the deal “The technology we’ve licensed represents a potential solution for this need, and one that our scientific team is eager to commercialize.” The agreement will let the company receive exclusive and worldwide intellectual property license. Both the companies will also work together to develop new production methods.

STVF recently appointed Dr. J. Jeremiah Mann as its new vice president of operations. He will also act as a senior agronomist.

STVF is involved in the business of cultivating and harvesting stevia leafs. The company also carries out various development plans for stevia products. It was earlier known as Legend Mining Inc. and changed its name in October 2011 to better reflect its core operations. The company is also engaged in other processes such as tissue culture, cultivation and laboratory propagation of stevia leaf. The company was formed in 2007 and is based out of Yuba City in California. STVF has not earned any revenue as on March 31, 2012.

]]> http://www.tech24.org/141271stevia-first-corp-stvf-stock-closes-down-in-friday%e2%80%99s-trading-session.html/feed 0 Southridge Enterprises Inc. (SRGE) Stock increases on Good Quarterly Numbers http://www.tech24.org/140811southridge-enterprises-inc-srge-stock-increases-on-good-quarterly-numbers.html http://www.tech24.org/140811southridge-enterprises-inc-srge-stock-increases-on-good-quarterly-numbers.html#comments Fri, 07 Sep 2012 13:02:11 +0000 Andrea Anderson http://www.tech24.org/?p=14081 Southridge Enterprises Inc. (OTC: SRGE) stock closed its latest trading session at $0.0032, up 33.33 percent from its previous close. Its latest trading volume has been recorded at 152 million shares, in contrast to the average daily trading volume of 15.16 million shares. The company’s market capitalization stands at $2.70 million. SRGE has 843.08 million shares outstanding in the market. The company stock’s beta is -14.22.

SRGE reported its operational and financial numbers for the fourth quarter of the financial year 2012. The company recorded record revenue and mineral production during the quarter. It produced 60 ton per day at Cinco Minas in Mexico during the quarter ending on August 31, 2012.  The company reported its revenue for the quarter at $3.14 million. It also processed more than 9,000 tons during the quarter. Cinco Minas is the Company’s flagship mineral property.

Michael Davies, President and CEO of SRGE said, “Today’s announcement of our record revenues clearly shows our undeniable success in making the Company’s goals a reality.” The company also reported that Mexican Mining Registry of the Cinco Minas mineral concession ownership has been update to duly reflect in the company’s name. SRGE is also looking to get its reporting status back to the Over the Counter bulletin board.

SRGE also recently commenced drilling program at its Cinco Minas property. The property is expected to have diamond reserves. The company is in the process of logging and sampling cores. The mine is reported to have 23.33 million oz. of mineral resources. SRGE is focusing on three main zones viz. the San Juan, the Famosa and the La Abra.

SRGE is involved in the business of acquiring, exploring and developing gold and silver mines. The company is mainly operational in Mexico and operates through its subsidiaries Southridge Minerals Inc. the company also has 100 percent stake in the Cinco Minas property. This property is spread over an area of 10,750 hectares and is located in the city of Guadalajara. SRGE also holds an option to acquire 40 percent interest in Esperanza property in Jalisco. The company is based out of Dallas in Texas and was established in 2004.

]]> http://www.tech24.org/140811southridge-enterprises-inc-srge-stock-increases-on-good-quarterly-numbers.html/feed 0 Penny Stock of the Day: Dynamic Ventures Corp. (DYNV) http://www.tech24.org/140631penny-stock-of-the-day-dynamic-ventures-corp-dynv.html http://www.tech24.org/140631penny-stock-of-the-day-dynamic-ventures-corp-dynv.html#comments Thu, 06 Sep 2012 17:22:47 +0000 Tammy Dugas http://www.tech24.org/?p=14063 Shares of Dynamic Ventures Corp. (OTC: DYNV), a provider of construction and related services in North America, are seeing a huge rally in today’s trading.

At last check, the penny stock of DYNV was trading 189.86% higher at $0.0400, with volume up from daily average of 87,160 to 13.32 million. The stock touched an intra-day high of $0.06 in today’s trading.

DYNV shares are soaring in today’s trading despite there being no recent news or development related to the company. The gains therefore could be due to some stock promotion activity.

A filing made by DYNV show that the company had total revenue of $4.588 million for the quarter ended June 29, 2012. This compares to total revenue of $4.266 million reported for the quarter ended March 30, 2012. DYNV’s gross profit for the quarter ended June 29, 2012 was $261,000, compared to $279,000 reported for the quarter ended March 30, 2012.

DYNV’s selling, general and administrative expenses for the June quarter totaled $424,000, compared to $443,000 reported for the March quarter. The company posted an operating loss of $165,000 for the June quarter. Operating loss for the March quarter also stood at $165,000.

DYNV reported a net loss of $514,000 for the quarter ended June 29, 2012, compared to a net loss of $229,000 reported for the quarter ended March 30, 2012.

At the end of the June quarter, the company had $385,136 in cash on its balance sheet. The company said in the filing that it plans to meet its cash requirements for the next 12 months through operations and external sources, which includes a combination of debt financing and equity financing through private placements. The company noted in the filing that it is currently not in good short-term financial standing and has a working capital deficit.

]]> http://www.tech24.org/140631penny-stock-of-the-day-dynamic-ventures-corp-dynv.html/feed 0 Medical Marijuana Inc. (MJNA) Closes Up in Wednesday’s Trading Session http://www.tech24.org/140331medical-marijuana-inc-mjna-closes-up-in-wednesday%e2%80%99s-trading-session.html http://www.tech24.org/140331medical-marijuana-inc-mjna-closes-up-in-wednesday%e2%80%99s-trading-session.html#comments Thu, 06 Sep 2012 13:08:24 +0000 Matt Prior http://www.tech24.org/?p=14033 Medical Marijuana Inc. (OTC: MJNA) traded in the range of $0.05 and $0.061 during its latest trading session. The stock opened at $0.05 and closed at $0.061, up 14.23 percent from its previous close of $0.06. MJNA recorded the volume of 7.97 million shares. Its average daily trading volume stands at 3.59 million shares. The company stock has traded in the range of $0.01 and $0.11 during its past 52 weeks. MJNA has market capitalization of $11.80 million. The company stock is trading at level to both the short term 20 days moving price and long term 50 days moving average price of $0.06. MJNA stock has beta of 5.76.

MJNA has entered into a number of new collaborations for the purpose of promoting its Dixie X brand. The company signed an agreement in New Mexico and Oregon to distribute its products through medical marijuana dispensaries. MJNA also reported that Dixie X brand of products are made from hemp and are thus legal in all 50 states in the US. The company has inked deal with Sacred Garden in Santa Fe. Tripp Keber, CEO and President of Red Dice Holdings said, “We are excited to begin marketing our Hemp Wellness CBD line of Dixie X products through these important and carefully selected partners in New Mexico and Oregon.”

MJNA has also launched a new website for the online sale of its Dixie X line of products. The company added, “We are pleased to launch the Dixie X products on our scheduled release date of September 5th. The Red Dice team has worked diligently to support this national launch.” The company has also collaborated with WeedMaps for launching nationwide marketing campaign for its products.

MJNA is engaged in the business of industrial hemp and medical marijuana. The company produces various products including proprietary and patented cannabinoid products. MJNA also licenses out its labeling, tracking, testing and production methods. MJNA also deals in wellness products. The company was formed in 2009 and it is based out of San Diego in California.

]]> http://www.tech24.org/140331medical-marijuana-inc-mjna-closes-up-in-wednesday%e2%80%99s-trading-session.html/feed 0 StemCells Inc. (STEM) Stock rising in Mid-day Session Today; Presents Positive Data for Spinal Injury Therapy http://www.tech24.org/140151stemcells-inc-stem-stock-rising-in-mid-day-session-today-presents-positive-data-for-spinal-injury-therapy.html http://www.tech24.org/140151stemcells-inc-stem-stock-rising-in-mid-day-session-today-presents-positive-data-for-spinal-injury-therapy.html#comments Tue, 04 Sep 2012 16:38:23 +0000 Shaun Johnson http://www.tech24.org/?p=14015 StemCells Inc. (OTC: STEM) is trading in the range of $2.18 and $2.67 during Monday’s trading session. The stock opened at $2.51 and is currently at $2.27, up 4.56 percent from its previous close of $2.17. STEM recorded the volume of 10.334 million shares. Its average daily trading volume stands at 1.894 million shares. The company stock traded in the range of $0.59 and $2.55 during its past 52 weeks. STEM has market capitalization of $67.51 million and it reported its latest Earnings per Share at -$1.09. The company has 30.41 million shares outstanding and institutional investors own 8 percent of its share capital. The company stock is trading below both the short term 20 days moving price of $2.28 and long term 50 days moving average price of $2.32. STEM stock has beta of 0.42.

STEM reported positive interim data for its spinal cord injury trial. The company said that the data continues to show favorable safety profile for the therapy. It also said that two out of the three patients showed considerable gains in sensory function. The company presented the data at the 51st Annual Scientific Meeting of the International Spinal Cord Society. The meeting is being held in London. Dr. Armin Curt,  Professor and Chairman of the Spinal Cord Injury Center at Balgrist University Hospital, University of Zurich and Principal Investigator said, “As with the three-month assessments, these three patients have tolerated the cell transplantation very well, and we have no safety concerns at this point.”

STEM is testing the efficacy of using purified human neural stem cells for the purpose of treating chronic spinal cord injury.

STEM is a biopharmaceutical company. It is involved in the process of researching, developing and marketing stem cells therapies. The company also deals in the development of related tools to be used by industry and academia. STEM has various drug candidates in the pipeline. The company’s major candidate is HuCNS-SC cell. It is currently carrying out phase I of the testing of the therapy. The company also sells technologies and tools to biotech companies. STEM was formed in 1988. The company is based out of Newark, California.

]]> http://www.tech24.org/140151stemcells-inc-stem-stock-rising-in-mid-day-session-today-presents-positive-data-for-spinal-injury-therapy.html/feed 0 Penny Stock in Focus: Pristine Solutions Inc. (PRTN) http://www.tech24.org/139891penny-stock-in-focus-pristine-solutions-inc-prtn-2.html http://www.tech24.org/139891penny-stock-in-focus-pristine-solutions-inc-prtn-2.html#comments Tue, 04 Sep 2012 12:24:23 +0000 Arnulfo Saucedo http://www.tech24.org/?p=13989 Shares of Pristine Solutions Inc. (OTC: PRTN), holder of intellectual property and global marketing rights to Tropine 3 through its recently acquired wholly owned subsidiary, ended marginally lower in Friday’s trading session.

The penny stock of PRTN ended the day 0.97% lower at $0.410, with volume at 7.82 million. The stock gained 6.49% in the last three trading sessions.

PRTN’s recently acquired subsidiary, Eaton Scientific Systems Ltd. on Friday provided an update on comments made by Dr. Hootan Melamed, whose Beverly Hills, California-based Rox San Pharmacy is the original compounding Pharmacy for Tropine 3, a novel indication of Homatropine in oral suspension.

Dr. Melamed, who has filed the patent for the drug’s new indication for the non-hormonal treatment of hot flashes in pre-menopausal, peri-menopausal, and post-menopausal women, said that over the last six years, the Rox San Pharmacy team has been compounding Tropine 3 for southern California doctors that prescribe the drug to their patients for the treatment of hot flashes. Dr. Melamed said that based on interactions with doctors and patients, he believes that Tropine 3 users have had a generally very positive response to the drug with no pronounced negative side-effects.

Dr. Melamed believes that women across America and around the world could benefit from open access to Tropine 3.

Dr. Melamed’s Rox San Pharmacy has more than 40 years of experience with a highly qualified and educated team of pharmacists, technicians and chemists to custom prepare high-quality compounded and manufactured medications using several unique delivery systems including lozenges, nasal spray, cream, lotion, or transdermal gel. Rox San’s services are used by a variety of health care participants, which include drug developers, dermatologists, plastic surgeons, orthopedic surgeons, and pain care specialists.

Eaton Scientific said that it is currently in advanced stage discussions with Rox San Pharmacy to provide expanded and ongoing compounding support during the highly anticipated Tropine 3 FDA compliant clinical trials expected to start in September.

]]> http://www.tech24.org/139891penny-stock-in-focus-pristine-solutions-inc-prtn-2.html/feed 0